J Am Pharm Assoc (2003). 2019 Nov-Dec;59(6):792-796. doi: 10.1016/j.japh.2019.06.013. Epub 2019 Jul 16.
To compare examination pass rates among different eligibility cohorts for initial board certification in 6 recognized pharmacy practice specialties.
Retrospective observational cohort study.
Practicing U.S. pharmacists who were approved candidates for initial board certification examinations in the following Board of Pharmacy Specialties (BPS)-recognized specialties: ambulatory care pharmacy, critical care pharmacy, oncology pharmacy, pediatric pharmacy, pharmacotherapy, and psychiatric pharmacy.
The number and percentage of BPS-approved candidates that pass initial board certification examinations differentiated by specialty and eligibility pathway (i.e., completion of postgraduate residency training or demonstration of postlicensure specialized practice experience).
Initial board certification examination outcome (i.e., pass or fail) was assessed for a total of 15,171 candidates from Fall 2015 to Fall 2018. Pass rates for that period based on eligibility pathway (e.g., completion of a PGY-2 specialty residency, completion of a PGY-1 residency plus 1-2 years of postlicensure specialized practice experience, or 3-4 years of postlicensure specialized practice experience) were, respectively as follows: ambulatory care pharmacy (n = 2081): 94%, 84%, and 55% (P < 0.0001); critical care pharmacy (n = 2111): 99%, 94%, and 79% (P < 0.0001); oncology pharmacy (n = 1195) 93%, 75%, and 50% (P < 0.0001); pediatric pharmacy (n = 1119): 87%, 73%, and 57%; (P < 0.0001); pharmacotherapy (n = 8368): 88%, 59% (P < 0.0001); and psychiatric pharmacy (n = 477): 93%, 72%, 49% (P < 0.0001).
From 2015 to 2018, the percentage of BPS-approved candidates that passed initial board certification examinations in ambulatory care pharmacy, critical care pharmacy, oncology pharmacy, pediatric pharmacy, pharmacotherapy, and psychiatric pharmacy was significantly higher for cohorts deemed to be board eligible based on completion of postgraduate residency training.
比较 6 个认可的药学实践专业中初始委员会认证的不同合格人群的考试通过率。
回顾性观察队列研究。
已通过美国药学委员会专业认证（BPS）认可的专业（即完成研究生住院医师规范化培训或展示毕业后专业实践经验），有资格参加以下药学委员会专业（BPS）认可的专业初始委员会认证考试的执业美国药剂师：门诊药房、重症监护药房、肿瘤药房、儿科药房、药物治疗学和精神药理学。
根据专业和资格途径（即完成研究生住院医师规范化培训或展示毕业后专业实践经验）对通过初始委员会认证考试的 BPS 认可候选人的数量和百分比进行区分。
2015 年秋季至 2018 年秋季，共评估了 15171 名符合条件的候选人的初始委员会认证考试结果（即通过或失败）。基于资格途径（例如，完成 PGY-2 专业住院医师规范化培训、完成 PGY-1 住院医师培训加 1-2 年毕业后专业实践经验或 3-4 年毕业后专业实践经验）的那段时间的通过率分别为：门诊药房（n=2081）：94%、84%和 55%（P<0.0001）；重症监护药房（n=2111）：99%、94%和 79%（P<0.0001）；肿瘤药房（n=1195）：93%、75%和 50%（P<0.0001）；儿科药房（n=1119）：87%、73%和 57%（P<0.0001）；药物治疗学（n=8368）：88%、59%（P<0.0001）；精神药理学（n=477）：93%、72%、49%（P<0.0001）。
2015 年至 2018 年，在门诊药房、重症监护药房、肿瘤药房、儿科药房、药物治疗学和精神药理学方面，通过初始委员会认证考试的 BPS 认可候选人的百分比，对于被认为有资格基于完成研究生住院医师规范化培训的候选人来说显著更高。
